在免疫疗法时代克服蛋白酶体抑制剂耐药性
Bonell Patiño-Escobar1, Alexis Talbot2, Arun P Wiita3
1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
Trends in pharmacological sciences
|June 21, 2023
概括
蛋白质酶抑制剂 (PI) 对多发性骨髓瘤有希望,但耐药性是一个挑战. 结合免疫疗法和向治疗的新策略可能会克服耐药性,开启治疗的新时代.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 蛋白质酶抑制剂 (PI) 对多发性骨髓瘤有效,但不能治愈.
- 对PI的耐药性仍然是一个重大的临床挑战.
- 新兴的研究探索了向蛋白质平衡和代谢适应以克服PI抵抗.
研究的目的:
- 审查目前克服多发性骨髓瘤中蛋白酶体抑制剂耐药性的策略.
- 探索免疫疗法在抗PI多发性骨髓瘤中的潜力.
- 提出一个统一的药理学方法,整合免疫疗法和向疗法.
主要方法:
- 关于蛋白酶体抑制剂耐药性机制的最新进展的文献综述.
- 对多发性骨髓瘤新兴免疫治疗策略的分析.
- 结合治疗方法的概念框架开发.
主要成果:
- 针对替代蛋白质稳态通路和线粒体代谢是当前的战略.
- 免疫疗法在抗PI的多发性骨髓瘤中表现出高效,独立于特定的抵抗机制.
- 建议使用药理学策略来增强免疫治疗的脆弱性.
结论:
- 在多发性骨髓瘤中克服蛋白酶体抑制剂耐药性需要新的治疗策略.
- 免疫疗法为治疗抗PI耐药性疾病提供了一个有前途的途径.
- 结合免疫疗法和向药物的统一方法可能为骨髓瘤治疗提供一个新的范式.
更多相关视频
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


